Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis.
Evaluation of a smartphone platform as a wireless interface between tongue drive system and electric-powered wheelchairs.
Highlights in Ulcerative Colitis From Digestive Disease Week 2022: Commentary.
Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
The use of tofacitinib in the treatment of inflammatory bowel disease.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 04; 17(5):818-823.
View in:
PubMed
subject areas
Biological Products
Drug Approval
Humans
Inflammatory Bowel Diseases
authors with profiles
David Rubin